Agape Atp Corporation ATPC

Q2 FY2026 · ended Jun 30, 2026 · Revenue $13,693, -93.4% YoY · Filed Aug 14, 2026

Agape Atp Corporation (ATPC) files with the SEC under industry code 8000, Services-Health Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $13,693 and net income of $149,437. As of Jun 30, 2026 it held $64,829 in cash and investments and $62,681 in total debt.

Revenue
$13,693
-93.4% vs year-ago quarter
Net income
$149,437
+124.0% vs year-ago quarter
Operating cash flow
$-110,318
+77.7% vs year-ago quarter
Free cash flow
$-1.45M
EPS
$0.15
+124.2% vs year-ago quarter
Dividend per share
None
Shares outstanding
1.00M
-98.0% vs year-ago quarter
Net cash
$2,148
Q2 FY2026
Operating margin
-239.0%
TTM

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
ATPC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Kuala Lumpur, Malaysia
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1713210

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$13,693
$273,658
$399,133
$370,593
$207,029
Operating income
-$550,975
-$677,372
-$1.3M
-$601,321
-$621,534
Net income
$149,437
-$340,906
-$376,937
-$586,827
-$623,246
Diluted EPS
$0.15
-$0.33
$0.00
-$0.01
-$0.62
Operating cash flow
-$110,318
-$394,770
-$208,348
-$256,742
-$494,458
Total assets
$25.0M
$24.9M
$24.6M
$24.4M
$24.6M
Total liabilities
$3.0M
$2.8M
$2.2M
$1.6M
$1.3M
Stockholders' equity
$22.1M
$22.1M
$22.5M
$22.8M
$23.4M
Cash and investments
$64,829
$255,514
$112,330
$150,592
$236,168
Total debt
$62,681
$180,402
$229,786
$247,807
$293,036

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-K Annual report Apr 13, 2026 Dec 31, 2025
8-K Current report
Listing notice
Mar 12, 2026 Mar 12, 2026
8-K Current report
Material agreement
Mar 10, 2026 Mar 10, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Feb 6, 2026 Feb 6, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.